Efficacy and safety of lixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: the lixiLan-L randomized trial
Shop 100% original products from top brands, enjoy fast 2-hour delivery in Kuwait, free medical consultations, 24/7 support, and a seamless, secure shopping experience tailored to your everyday wellness and care needs
This simple habit ensures you hit your protein targets even on days when eating feels like a chore
Push up the plunger to expel almost all the air (fig
GLP-1s are unlikely to deliver therapeutic value when so many individuals stop treatment after two years, but the findings also illustrate the need for obesity care management programs to improve adherence," David Lassen, chief clinical officer at Prime/MRx, said in a news release
Early findings suggest promising results, but long-term safety data remain limited and are under active investigation